LKQ Corp (LKQ) Q4 2025 earnings review
Margins Collapse, Strategic Review Initiated
LKQ delivered a messy Q4 where a 2.7% revenue gain masked a severe deterioration in profitability. While the Specialty segment rebounded significantly, the core North American wholesale business saw margins collapse by 380 basis points YoY. Adjusted Net Income fell 26%, and GAAP Net Income halved. Acknowledging the struggle, the Board initiated a review of strategic alternatives—Wall Street code for a potential breakup or sale—and launched a restructuring plan to cut costs. The 'For Sale' sign is now the primary thesis, overshadowing the weak operational results.
🐂 Bull Case
After quarters of weakness, the Specialty segment posted impressive 7.8% organic revenue growth, signaling that the destocking headwinds in this discretionary category have firmly ended.
The initiation of a 'comprehensive review of strategic alternatives' effectively puts a floor under the stock price. Whether through a sale of the Specialty segment or the entire company, management is prioritizing unlocking shareholder value over empire building.
🐻 Bear Case
North America Wholesale EBITDA margin collapsed from 16.5% in 24Q4 to 12.7% in 25Q4. Losing nearly 400bps of margin in the company's most important profit pool suggests severe pricing pressure or inability to manage overheads.
Despite a leadership overhaul, Europe reported negative 4.8% organic revenue growth. The region continues to face macro headwinds, and the turnaround is taking longer than investors were promised.
⚖️ Verdict: 🔴
Bearish on operations, Neutral on valuation due to M&A potential. The core business is deteriorating (margins down, organic growth negative in major segments), but the strategic review announcement provides a potential exit ramp for investors.
Key Themes
North American Profitability Shock
The most alarming data point in the report is the degradation of North American Wholesale margins. Segment EBITDA fell to $174M from $226M a year ago (-23%), despite revenue being flat. The margin compressed to 12.7% from 16.5%. Management cited 'pricing discipline' in the release, but the numbers suggest cost inflation or mix shift is eating the bottom line alive.
Specialty Segment Inflection
Accelerating. Specialty was the sole bright spot, swinging to +7.8% organic growth after a year of declines (e.g., -4.5% in FY24). While margins remain thin (4.5%), the volume return indicates the end of the cyclical downturn in RV and specialty parts demand.
Strategic Alternatives Review
Following the divestiture of the Self Service segment and the exploration of a Specialty sale, the Board has now opened the door to a wider breakup or sale of the company. There is no deadline, but this explicit announcement suggests management believes the public markets are undervaluing the sum-of-the-parts, or that operational fixes are too slow.
Europe: Shrinking Footprint
Europe continues to shrink organically (-4.8%). While reported revenue grew due to FX (+7.7% impact), the underlying business is contracting. EBITDA margin dropped to 8.3% from 10.1% a year ago. The 'simplification' strategy is not yet translating to bottom-line stability.
Restructuring & Cost Cuts
A new restructuring plan was approved to generate >$50M in annualized savings (half realized in 2026). However, this comes with a $60-70M charge. This feels like a defensive move to protect margins that are already in freefall rather than an offensive efficiency play.
Other KPIs
Missed the trend. Down 24.4% YoY from $0.78. This significant earnings contraction occurred despite revenue being up, highlighting severe negative operating leverage.
Stable. Up slightly from $810M in FY24. Despite earnings pressure, cash conversion remains decent. Management returned $469M to shareholders (buybacks + dividends), showing discipline in capital allocation.
Decelerating. Down 140 basis points from 39.3% in 24Q4. This is a critical deterioration indicating either pricing power loss or rising input costs that cannot be passed on.
Guidance
Stable/Low Growth. Implies a very slow recovery. The midpoint (0.5%) is barely positive, suggesting management sees no V-shaped recovery in North America or Europe.
Stagnant. The midpoint ($3.05) is roughly flat vs FY25 Actuals ($3.01). Given the easy comparisons from a weak 2025, this guidance is underwhelming and suggests margin pressure will persist through 2026.
Decelerating. The midpoint ($775M) is below FY25 actuals ($847M). Cash generation efficiency is declining alongside profitability.
Key Questions
North America Margin Bridge
Segment EBITDA margins in North America collapsed 380 basis points YoY. How much of this is structural cost inflation vs. competitive pricing pressure, and why hasn't the lean operating model protected profitability?
Strategic Review Timeline
With the divestiture of Self Service complete and Specialty exploration underway, does the 'comprehensive review' imply a willingness to sell the core Wholesale business, and is there a target timeline for these decisions?
Europe Organic Decline
Organic revenue in Europe fell nearly 5%. Is this purely macro-driven, or is LKQ losing share to competitors in key markets like the UK and Germany?